These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2808786)

  • 61. Treatment of collodion babies with a topical preparation containing lactic acid.
    Erdem G
    Turk J Pediatr; 1982; 24(2):97-101. PubMed ID: 7051499
    [No Abstract]   [Full Text] [Related]  

  • 62. Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis.
    Stein Gold L; Bagel J; Lebwohl M; Lin T; Martin G; Pillai R
    J Drugs Dermatol; 2018 Dec; 17(12):1290-1296. PubMed ID: 30586261
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
    Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
    J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin.
    Danby SG; Brown K; Higgs-Bayliss T; Chittock J; Albenali L; Cork MJ
    Skin Pharmacol Physiol; 2016; 29(3):135-47. PubMed ID: 27251427
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
    Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
    Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
    Kuhlman DS; Callen JP
    Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Severely dry skin: clinical evaluation of a highly effective therapeutic lotion.
    Kantor I; Ballinger WG; Savin RC
    Cutis; 1982 Sep; 30(3):410-1, 415-6, 419-24. PubMed ID: 7172738
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: A Randomized Placebo-Controlled Trial.
    Stoddard M; Herrmann J; Moy L; Moy R
    J Drugs Dermatol; 2017 Oct; 16(10):1030-1034. PubMed ID: 29036257
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris.
    Charakida A; Charakida M; Chu AC
    Br J Dermatol; 2007 Sep; 157(3):569-74. PubMed ID: 17635508
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Skin xerosis. Clinical report on the effect of a moisturizing soap bar.
    Boccanfuso SM; Cosmet L; Volpe AR; Bensel A
    Cutis; 1978 May; 21(5):703-7. PubMed ID: 348407
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of venous ulcers using variclene.
    Allenby CF; O'Callaghan R; Vollum DI
    Br J Clin Pract; 1983; 37(11-12):382-4. PubMed ID: 6671080
    [No Abstract]   [Full Text] [Related]  

  • 72. Efficacy of an emollient cream in the treatment of xerosis in diabetic foot: a double-blind, randomized, vehicle-controlled clinical trial.
    Martini J; Huertas C; Turlier V; Saint-Martory C; Delarue A
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):743-747. PubMed ID: 27997725
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ichthyosis bullosa of Siemens: a topical therapy option.
    Sanclemente G; Falabella R; Escobar CE; Arroyave JA
    Arch Dermatol; 1999 Feb; 135(2):217-8. PubMed ID: 10052422
    [No Abstract]   [Full Text] [Related]  

  • 74. Do urea/ammonium lactate combinations achieve better skin protection and hydration than either component alone?
    Gloor M; Fluhr J; Lehmann L; Gehring W; Thieroff-Ekerdt R
    Skin Pharmacol Appl Skin Physiol; 2002; 15(1):35-43. PubMed ID: 11803256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis.
    Pariser DM; Pariser RJ
    Cutis; 1994 Jul; 54(1):43-4. PubMed ID: 7924451
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea.
    Wu JJ; Weinstein GD; Kricorian GJ; Kormeili T; McCullough JL
    Clin Exp Dermatol; 2007 Nov; 32(6):693-5. PubMed ID: 17868391
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A double-blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pityriasis (tinea) versicolor.
    Hull CA; Johnson SM
    Cutis; 2004 Jun; 73(6):425-9. PubMed ID: 15224788
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel.
    Andersch B; Lindell D; Dahlén I; Brandberg A
    Gynecol Obstet Invest; 1990; 30(2):114-9. PubMed ID: 2245947
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study.
    Udompataikul M; Srisatwaja W
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):660-5. PubMed ID: 20840345
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Innovation of the antiepileptic therapy with magnesium lactate.
    Steidl L; Tolde I; Svomová V
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():271-82. PubMed ID: 2977901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.